Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Total Non-Current Liabilities: 2015-2019

Historic Total Non-Current Liabilities for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $24.0 million.

  • Outlook Therapeutics' Total Non-Current Liabilities fell 37.57% to $19.1 million in Q2 2020 from the same period last year, while for Jun 2020 it was $19.1 million, marking a year-over-year decrease of 37.57%. This contributed to the annual value of $24.0 million for FY2019, which is 39.46% down from last year.
  • Latest data reveals that Outlook Therapeutics reported Total Non-Current Liabilities of $24.0 million as of FY2019, which was down 39.46% from $39.6 million recorded in FY2018.
  • In the past 5 years, Outlook Therapeutics' Total Non-Current Liabilities ranged from a high of $62.3 million in FY2015 and a low of $24.0 million during FY2019.
  • Its 3-year average for Total Non-Current Liabilities is $37.5 million, with a median of $39.6 million in 2018.
  • Per our database at Business Quant, Outlook Therapeutics' Total Non-Current Liabilities plummeted by 54.81% in 2016 and then skyrocketed by 73.71% in 2017.
  • Outlook Therapeutics' Total Non-Current Liabilities (Yearly) stood at $62.3 million in 2015, then slumped by 54.81% to $28.1 million in 2016, then surged by 73.71% to $48.9 million in 2017, then decreased by 19.04% to $39.6 million in 2018, then slumped by 39.46% to $24.0 million in 2019.